Dual Therapeutics, LLC — Form D/A
Dual Therapeutics, LLC of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2014-10-21. The offering totals $15.3M, of which $6.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-10-21
- Form: D/A
- Accession: 0001575797-14-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.3M
- Amount sold: $6.4M
- Remaining: $8.9M
- Investors: 11
- Date of first sale: 2013-07-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-199836
Issuer
- Name: Dual Therapeutics, LLC
- CIK: 0001575797
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 423 W. 127TH STREET, NEW YORK, NY, 10027
- Phone: 216-455-3216
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Michael Ohlmeyer | Director | New York, NY |
| Baiju Shah | Director | Cleveland, OH |
| DAVID U'PRICHARD | Director | LONDON, X0 |
| Al Hawkins | Promoter | Cleveland, OH |
| Baiju Shah | Promoter | Cleveland, OH |
Other filings by this issuer (2)
More